leon-nanodrugs
Latest round
- Series D
Last raised
- Aug 2024
Total raised
- $21M
Investors
- 10
About leon-nanodrugs
Leon Nanodrugs focuses on advanced manufacturing solutions for nanocarrier production, primarily utilizing their proprietary FR-JET technology. This technology enables the creation of homogeneous nanoparticle-based drug delivery systems, which serve as carrier vehicles for the protection and targeted delivery of therapeutic substances including genetic material, RNA, and small molecules. The systems are designed for both small-scale personalized medicine and larger commercial batch production, thereby addressing the diverse needs of pharmaceutical, biotechnology, and Contract Development and Manufacturing Organizations (CDMOs).Leon Nanodrugs operates on a B2B model, directly engaging with pharmaceutical companies, biotech firms, and CDMOs to provide advanced manufacturing solutions. Revenue is generated through the sale of specialized equipment and technology, particularly the FR-JET systems, which are flagship products within their portfolio. These products are typically sold with tailored service agreements that may include installation, training, and ongoing technical support.
Who invested in leon-nanodrugs
10 investors across 3 rounds
See all investors in leon-nanodrugs
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about leon-nanodrugs
Who invested in leon-nanodrugs?
leon-nanodrugs has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has leon-nanodrugs raised?
leon-nanodrugs has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did leon-nanodrugs last raise money?
leon-nanodrugs's most recent round on record is a Series D, in Aug 2024.
What does leon-nanodrugs do?
Leon Nanodrugs focuses on advanced manufacturing solutions for nanocarrier production, primarily utilizing their proprietary FR-JET technology.
Where is leon-nanodrugs headquartered?
leon-nanodrugs is headquartered in Munich, Germany.
Which VCs invest in companies like leon-nanodrugs?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at leon-nanodrugs's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like leon-nanodrugs? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.